Release Testing. IceCure shall test each applicable batch or serial of Product in accordance with the Specification as defined in Exhibit 1.34 and the Quality Agreement. Prior to the Delivery, IceCure shall conduct inspection of the Product in accordance with IceCure’s standard lot release testing methods approved by Terumo in writing. The Parties shall agree in good faith upon such standard lot release-testing methods prior to the delivery of any Product (other than the Initial Order). IceCure shall send to Terumo a written certification of the results for each shipment. At Terumo costs and expenses, Terumo or its Affiliates shall conduct the incoming inspections and testing of the Product as set forth in the Specification as defined in Exhibit 1.34 and the Quality Agreement and as required by Applicable Laws and applicable Regulatory Authorities in the Territory. Terumo shall be responsible for final Product release testing for the Product in the Territory.
Release Testing. Pacira shall undertake, or have undertaken by the Third Party Manufacturer, Quality Control and Release of each Batch of the Finished Product using the analytical testing methodologies which are set forth in the Specifications and any Marketing Authorization and as required by cGMP and any other Applicable Laws.
Release Testing. Each Party will be responsible for release testing and the release of the Product (or component thereof), for that portion of the supply chain for which such Party is responsible.
Release Testing. Supplier shall perform release testing of all batches of Product in accordance with the Product Specifications and the Master Batch Record, to determine whether such batches of Product meet the requirements set out in the Product Specifications. Supplier shall ensure that:
(a) its quality control or assurance department approves each batch of Product for release promptly following successful completion of release testing; and
(b) its quality assurance department does not release any batch of Product that does not meet the requirements set out in the Product Specifications without prior written consent of customer. Supplier shall prepare a Certificate of Analysis, in the form set out in Exhibit D, setting out the results of the release testing and which shall be included with each batch of Product shipped to Customer.
Release Testing. Prior to release of the Products to finished goods inventory, WuXi Biologics shall test the Products in accordance with the testing procedures described in the Specifications.
Release Testing. If required, all Products supplied by Auxilium shall be tested and released by Auxilium in the EU until such time as Transfer of the Marketing Authorization occurs in at least one EU country and such Marketing Authorization is amended to identify Ipsen as the importer of the Product. Thereafter, if required, all Products supplied by Auxilium shall be tested and released in the EU by Ipsen, provided, ** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. however, that Auxilium shall reimburse Ipsen for laboratory fees for such release testing not to exceed four hundred twenty-five pounds (£ 425) for the first batch of Product and three hundred fifty-five pounds (£ 355) for subsequent batches received in the same shipment. Testing and release of Product in non-EU countries, if required, shall be performed by Ipsen at its sole cost and expense.
Release Testing. Any Patches, Updates, Upgrades or other software developed as part of the Support and Maintenance Services will be tested to Cabot’s normal standards of software testing and will not undergo formal [Validation Testing]. If the Licensee requests that Cabot carry out Validation Testing of any released software then Cabot may do so at its sole discretion provided that the Licensee agrees to pay for this additional service at the rate set out in section 1.7. 26/06/2006 Page 41 of 47
Release Testing. The QLT will establish procedures for release testing EQW Product Manufactured for Lilly to ensure that EQW Product conforms to Applicable Laws.
Release Testing. The DWT will establish procedures for release testing of Devices Manufactured by Lilly to ensure that such Devices conform to Applicable Laws.
Release Testing. Prior to release of the 89bio Products to finished goods inventory, Provider shall test the 89bio Products in accordance with the testing procedures described in the Specifications.
